Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2020
Pharma News, 2020
California may be the first state to develop its own generic drugs
SACRAMENTO — California is poised to become the first state to develop its own line of generic drugs, targeting soaring drug prices and stepping into a fiercely competitive drug market dominated by ...
Sanofi, GSK to start potential COVID-19 vaccine trial
Paris-based pharmaceutical company Sanofi and pharma giant GSK announced Thursday they are starting clinical trials of their COVID-19 vaccine.
WHO updates clinical care guidance with corticosteroid recommendations
On 2 September, WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222
Oxford, UK – 1 September, 2020.
Jubilant Life Sciences seeks nod to roll out Remdesivir tablet
NEW DELHI.
Honeybee venom compound shown to kill aggressive breast cancer cells: Aussie research
SYDNEY, Sept.
Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program
FOSTER CITY, Calif.
AZ' Imfinzi bags new approval for lung cancer
AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union for the first-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) in combination...
FDA willing to fast track coronavirus vaccine before phase three trials end
The chief of the Food and Drug Administration is prepared to bypass the full federal approval process in order to make a Covid-19 vaccine available as soon as possible, according to an interview in th...
Nestlé to acquire Aimmune Therapeutics
Nestlé and Aimmune Therapeutics, Inc.
Sanofi provides update on Kevzara® (sarilumab) Phase 3 trial in severe and critically ill COVID-19 patients outside the U.S.
PARIS – September 1, 2020 – Sanofi today announced that the global Phase 3 trial investigating intravenously administered Kevzara® (sarilumab) at a dose of 200 mg or 400 mga in severely o...
Vir Biotechnology and GSK start phase 2/3 study of COVID-19 antibody treatment
Vir Biotechnology, Inc.
25
26
27
28
29
30
31
32
33
